BackKiromic BioPharma Overview

Kiromic BioPharma Total Assets

Latest total assets for KRBP: $8.5M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$8.54M
↓ 29.78% YoYΔ $-3.62M vs prior year quarter

Peer average

Loading

Kiromic BioPharma Total Assets History

Loading

Kiromic BioPharma vs. peers: Total Assets Comparison

Loading

Kiromic BioPharma Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Kiromic BioPharma (KRBP) FAQ

Kiromic BioPharma (KRBP) currently reports a total assets of $8.5M as of December 2024. That compares with $12M in the prior-year period — down 29.8% year over year. Use the charts on this page to explore Kiromic BioPharma's total assets history and peer comparisons.

Kiromic BioPharma's total assets decreased from $12M to $8.5M — a 29.8% year-over-year decrease (period ending December 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Kiromic BioPharma reported $8.5M in total assets as of December 2024. That compares with $12M in the prior-year period — down 29.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $8.5M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Kiromic BioPharma, and consider following KRBP for alerts when major investors trade the stock.

Kiromic BioPharma is classified in the Healthcare sector. On total assets, it currently shows $8.5M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing KRBP with unrelated industries.